Population studies of GLP-1 users show measurable nutritional deficiencies developing over time
GLP-1 receptor agonists including Ozempic (semaglutide), as well as alternatives like dulaglutide (Trulicity), liraglutide (Victoza), or exenatide, are all peptide-based injectable medications without any sulfonamide content
last night
The pathological changes associated with OA affect the entire joint, including the progressive degradation of articular cartilage, the subchondral bone remodeling, and the inflammation of the synovial membrane, all of which culminate in joint pain and dysfunctions [1], [2]
14 The QUALITY trial added enobosarm, a medication that activates muscle- and bone-building signals similar to testosterone but only in those tissues, to semaglutide in older adults with obesity